AstraZeneca

AstraZeneca reported Total CO2e Emissions - Market-Based Scope 1 + Scope 2 for the twelve months ending 31 December 2022 at 264 Kt (-4.2 /-1.6% y-o-y). Also positively, carbon intensity declined to 5.9 t (-1.3 /-18.1% y-o-y).

AstraZeneca's Scope 3 emissions rose to 6,388 Kt (+370/+6.2% y-o-y). The growth accelerated compared to the long-term upward trend (CAGR of +1.4% since 4Q'16).

The company is committed to reducing Scope 1 + 2 by 98% by 2026 from a base year 2015, which translates into the estimated reduction of -63 Kt per annum over the period of FY2023 - FY2026. This science-based target is aligned with Paris Agreement to limit global warming to 1.5°C above pre-industrial levels.